News

PharmExec15m
FDA Approves Label Update for Novartis’ Leqvio to Enable Twice-Yearly Monotherapy for LDL-C Management in Adults with Hypercholesterolemia
The updated label no longer requires Leqvio (inclisiran) to be used in combination with statins for low-density lipoprotein ...